The primary objective of this systematic review was to evaluate the existing studies on the associations between XO levels, activity, and/or expression at the fetal, maternal, and placental level, and major pregnancy pathologies such as HDP, GD, IUGR, PTB, and RPL. The gene discussed is XDH; the disease is fetal growth restriction.